- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana to present business update related to COVID-19 this Thursday
Dignitana AB shareholders, investors, analysts and media are invited to participate in a teleconference to provide an update on the Company and address the impact of the COVID-19 pandemic on the business.
The teleconference is scheduled for Thursday, April 2, 2020 from 16.00 - 17.00 CET. Dignitana CEO William Cronin will present the latest developments and answer questions from the market.
Questions should be submitted in advance by email to email@example.com no later than 17.00 on April 1, 2020.
The teleconference will be managed by Redeye. To participate, go to: https://www.redeye.se/live/dignitana-strategy-update-live The presentation will be recorded and posted afterward on the Dignitana website.
For More Information Contact
Investor Relations +1 469 518 5031 firstname.lastname@example.org
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com. Eric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 email@example.com www.penser.se